Abdulaziz A. AlSayyari, Ph.D. MBA

​Abdulaziz A. AlSayyari is a distinguished professional with extensive experience in the pharmaceutical and regulatory sectors. He has held pivotal roles such as Executive Director of Quality Evaluation for Medicinal Products and Director of the Evaluation of Biological Medicine at the Saudi Food and Drug Authority (SFDA), where he played a crucial part in ensuring the safety and efficacy of medicinal products in Saudi Arabia. His expertise in quality evaluation and biological medicine has significantly contributed to the advancement of healthcare standards in the region.

In addition to his regulatory accomplishments, Dr. AlSayyari has demonstrated a commitment to continuous professional development. He recently completed the Senior Executive Program at London Business School, an intensive four-week course that broadened his strategic leadership skills. Further enhancing his business acumen, he earned an Executive MBA focused on Innovation and Business Development from IMD Business School. These academic pursuits underscore his dedication to integrating innovative strategies within the pharmaceutical industry, aiming to improve healthcare delivery and patient outcomes.

Master of Business Administration (MBA), Business Administration and Management

IMD Business School (Nov 2023 – Feb 2025)

Senior Executive Program 107, Business Administration, Management and Operations

London Business School (Nov 2022)

Doctor of Philosophy (PhD), Bioprocess Engineering

Wageningen University & Research (2013)

Biotechnology

University of Nottingham (2009)

Medical Biotechnology

Winston-Salem State University (2004)

Executive Director of Quality Evaluation for Medicinal Products

Saudi Food and Drug Authority (SFDA) (Aug 2021 – Jan 2024)

Director, The Evaluation of Biological Medicine

Saudi Food and Drug Authority (SFDA) (Aug 2018 – Aug 2021)

Biotechnology and Biosimilars Products Reviewer

Saudi Food and Drug Authority (SFDA) (Nov 2017 – Aug 2021)

Biosimilar Products Reviewer

Saudi Food and Drug Authority (SFDA) (2008 – 2013)